Reframe Workplace Conflicts
FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer
On August 17, 2017, the U.S. Food and Drug Administration granted regular approval to olaparib tablets for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.
- Read more about FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer
- Add new comment
FDA Approves Inotuzumab Ozogamicin for Relapsed, Refractory B-Cell Precursor ALL
On Aug. 17, 2017, the U.S. Food and Drug Administration approved inotuzumab ozogamicin for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
- Read more about FDA Approves Inotuzumab Ozogamicin for Relapsed, Refractory B-Cell Precursor ALL
- Add new comment
Time Is Short When Addressing Hypersensitivity Reactions to Chemotherapy
Between administering antineoplastic agents, monitoring patient vitals, and preparing patients for treatment, oncology nurses are required to balance their attention between many intricate tasks. Chief among the division of duties is that oncology nurses closely monitor their patients for hypersensitivity reactions (HSRs) to prescribed agents.
- Read more about Time Is Short When Addressing Hypersensitivity Reactions to Chemotherapy
- Add new comment
The Impact of PCHETA on the Quality of Cancer Care
As a national nursing organization with a specialty in cancer care, ONS occupies a unique space in the healthcare public policy environment. When nurses speak, decision makers listen, because nurses are the most trusted healthcare providers. This is not an insignificant fact to those who decide how to implement health policy decisions through law and the regulatory system.
Homepage
Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs?
Many Americans use dietary supplements, including herbal products, in the belief that they are natural and safe. Patients with cancer use them often to enhance the effects or to reduce the adverse reactions of cancer treatments. However, few herbs have been thoroughly studied in humans. Therefore, their interactions with prescription drugs and the clinical relevance, remain undetermined. These interactions could be pharmacokinetic in nature when an herb alters the absorption, metabolism, or excretion of other drugs, or pharmacodynamic in which it affects the mechanism of action of other drugs when consumed together. Following are a few relevant herb-drug interactions encountered in the oncology setting.
- Read more about Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs?
- Add new comment
The Case of the Anxiety Answer
Kris is a 46-year-old newly diagnosed with stage III cervical cancer. She is an avid runner and vegetarian, and she believes strongly in taking care of herself. “I never thought I would get cancer,” she says. “I thought I did everything I could to avoid this.”
Trump Declares Opioid Crisis a National Emergency; Recent Poll Shows Health Care, Government Most Important to Americans; FDA Launches Campaign to Fight Youth E-Cigarette Use
Experts currently estimate that opioid addiction kills nearly 100 Americans every day, and the scale of the problem is continuing to grow. In response, President Trump to unofficially declared the opioid crisis a national emergency during a public statement from his golf resort in Bedminster, NJ, on August 10, 2017.
- Read more about Trump Declares Opioid Crisis a National Emergency; Recent Poll Shows Health Care, Government Most Important to Americans; FDA Launches Campaign to Fight Youth E-Cigarette Use
- Add new comment
How Are Patients Randomized to Cancer Clinical Trials?
Before any new treatment or approach is used with people in clinical trials, researchers work to understand its effects on cancer cells in the lab and in animals. Researchers design cancer clinical trials to test new ways to treat, detect, diagnose, and prevent cancer, and manage symptoms of cancer and side effects from treatment.